Bota Posted on 2026-04-03 10:06:00

Donald Trump Returns to Trade Tariffs - Up to 100% on Imported Medicines. Modifies Them for Metals

From Dorian Koça

Donald Trump Returns to Trade Tariffs - Up to 100% on Imported Medicines.

US President Donald Trump has signed into law additional tariffs on imported pharmaceuticals and a reversal of existing tariffs on metals. The decision comes exactly one year after he declared "Liberation Day" when he announced trade tariffs on all countries in the world.

The new tariffs on pharmaceutical products are aimed at increasing domestic production in the United States and could reach up to 100%. According to the White House, the measure aims to reduce dependence on imports and strengthen the American pharmaceutical industry.

Some countries are partially exempt from the new measures, as they have special agreements with Washington. Japan, South Korea, the European Union and Switzerland will see their medicines taxed at up to 15%, as stipulated in their respective agreements.

At the same time, tariffs on metals are being adjusted, in response - as the White House claims - to practices by companies that try to "artificially manipulate" the prices of their products to make them cheaper in the US market. Now, finished products containing mainly steel, aluminum or copper will be subject to tariffs of 25% on their total value, instead of 50% on the amount of metals they contain.

The new rules for metals will come into effect on Monday, while for pharmaceutical products, their implementation will begin after 120 to 180 days, depending on the size of the manufacturing companies.

The Trump administration's goal, an official said, is to have "the majority of licensed drugs manufactured in the United States." Generic drugs are exempt from the new measures. In addition, companies that commit to building factories in the United States will pay a reduced tariff of 20% until the end of President Trump's term.

Companies that apply "most-favored-nation" treatment to the prices of their drugs and commit to investing in the U.S. will be completely exempt from tariffs. Thirteen pharmaceutical companies have signed this agreement so far.

Live TV

Latest news
All news

Most visited